Literature DB >> 18796027

Cure, continence and quality of life after treatment for fistula-in-ano.

Shing Wong1, Michael Solomon, Philip Crowe, Kevin Ooi.   

Abstract

BACKGROUND: The best operation for high anal fistulas is difficult to nominate because they have varying cure and incontinence rates. The objective of this study was to quantify the relative importance of the outcomes of cure, continence and other quality-of-life (QOL) factors.
METHODS: A questionnaire was sent in October 2006 to patients with anal fistulas and to colorectal surgeons. Participants were asked to nominate up to five QOL domains. They were also asked to choose between two treatment options (with different cure and continence rates).
RESULTS: Seventy-five of 134 (56%) surgeons and 28 of 199 (14%) patients replied. Comparing draining and cutting setons, surgeons (57 of 71, six neutral) favoured the former and patients (15 of 27, four neutral) preferred the latter. Comparing mucosal advancement flap with cutting seton, both surgeons (71 of 75, four neutral) and patients (13 of 26, two neutral) preferred the former. There was greater uncertainty among surgeons when comparing draining seton (23) and mucosal advancement flap (33), with 18 neutral. Patients preferred the mucosal advancement flap (19) to draining seton (three) and four were neutral. In direct questioning of objectives, surgeons nominated continence, leakage, pain, cure and sepsis as the five most important QOL factors. Patients nominated independent activity, pain, continence, psychological health and leakage as their five factors.
CONCLUSION: Functional impairment and QOL do not necessarily correlate. The development of a validated specific QOL scale for patients with anal fistulas would be important to compare the results of different treatment options. This scale should include social and psychological factors in addition to the physical outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 18796027     DOI: 10.1111/j.1445-2197.2008.04616.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  7 in total

1.  Quality of life following surgery for recurrent fistula-in-ano.

Authors:  Sanjeewa A Seneviratne; Dharmabandhu Nandadeva Samarasekera; Wajantha Kotalawala
Journal:  Tech Coloproctol       Date:  2009-07-18       Impact factor: 3.781

Review 2.  Heterogeneity in outcome selection, definition and measurement in studies assessing the treatment of cryptoglandular anal fistula: findings from a systematic review.

Authors:  A J H M Machielsen; N Iqbal; M L Kimman; K Sahnan; S O Adegbola; G Kane; R Woodcock; J Kleijnen; U Grossi; S O Breukink; P J Tozer
Journal:  Tech Coloproctol       Date:  2021-05-08       Impact factor: 3.781

3.  Living with cryptoglandular anal fistula: a qualitative investigation of the patient's experience through semi-structured patient interviews.

Authors:  Nusrat Iqbal; Astrid J H M Machielsen; Stephanie O Breukink; Rebecca Woodcock; Gillian Kane; Laith Alrubaiy; Ugo Grossi; Merel L Kimman; Phil J Tozer
Journal:  Qual Life Res       Date:  2022-02-17       Impact factor: 3.440

4.  Ligation of Intersphincteric Fistula Tract Is Suitable for Recurrent Anal Fistulas from Follow-Up of 16 Months.

Authors:  Yansong Xu; Weizhong Tang
Journal:  Biomed Res Int       Date:  2017-02-08       Impact factor: 3.411

5.  The Ligation of Intersphincteric Fistula Tract Technique: A Preliminary Experience.

Authors:  Pasquale Cianci; Nicola Tartaglia; Alberto Fersini; Libero Luca Giambavicchio; Vincenzo Neri; Antonio Ambrosi
Journal:  Ann Coloproctol       Date:  2019-10-31

6.  Complex Anal Fistula: Long-Term Results of Modified Ligation of Intersphincteric Fistula Tract=LIFT.

Authors:  Mustafa Fevzi Celayir; Emre Bozkurt; Nurcihan Aygun; Mehmet Mihmanli
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2020-08-24

7.  Development and initial psychometric validation of a patient-reported outcome measure for Crohn's perianal fistula: the Crohn's Anal Fistula Quality of Life (CAF-QoL) scale.

Authors:  Samuel O Adegbola; Lesley Dibley; Kapil Sahnan; Tiffany Wade; Azmina Verjee; Rachel Sawyer; Sameer Mannick; Damian McCluskey; Paul Bassett; Nuha Yassin; Janindra Warusavitarne; Omar Faiz; Robin Phillips; Phil J Tozer; Christine Norton; Ailsa L Hart
Journal:  Gut       Date:  2020-12-03       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.